Trial Profile
Efficacy and safety of iguratimod as add-on therapy for patients with Rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Iguratimod (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 04 Dec 2015 New trial record